Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Titel:
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Auteur:
Matasar, Matthew J Capra, Marcelo Özcan, Muhit Lv, Fangfang Li, Wei Yañez, Eduardo Sapunarova, Katya Lin, Tongyu Jin, Jie Jurczak, Wojciech Hamed, Aryan Wang, Ming-Chung Baker, Ross Bondarenko, Igor Zhang, Qingyuan Feng, Jifeng Geissler, Klaus Lazaroiu, Mihaela Saydam, Guray Szomor, Árpád Bouabdallah, Krimo Galiulin, Rinat Uchida, Toshiki Soler, Lidia Mongay Cao, Anjun Hiemeyer, Florian Mehra, Aruna Childs, Barrett H Shi, Yuankai Zinzani, Pier Luigi